David Jin
2023 - Fortress Biotech
In 2023, David Jin earned a total compensation of $1.3M as Chief Financial Officer and Head of Corporate Development at Fortress Biotech, a 15% decrease compared to previous year.
Compensation breakdown
| Option Awards | $582,500 |
|---|---|
| Salary | $400,000 |
| Stock Awards | $330,400 |
| Other | $7,333 |
| Total | $1,320,233 |
Jin received $582.5K in option awards, accounting for 44% of the total pay in 2023.
Jin also received $400K in salary, $330.4K in stock awards and $7.3K in other compensation.
Rankings
In 2023, David Jin's compensation ranked 831st out of 2,238 executives tracked by ExecPay. In other words, Jin earned more than 62.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 831 out of 2,238 | 63rd |
Division Manufacturing | 483 out of 1,216 | 60th |
Major group Chemicals And Allied Products | 325 out of 683 | 52nd |
Industry group Drugs | 315 out of 654 | 52nd |
Industry Pharmaceutical Preparations | 218 out of 470 | 54th |
Source: SEC filing on April 5, 2024.
Jin's colleagues
We found two more compensation records of executives who worked with David Jin at Fortress Biotech in 2023.
News
Fortress Biotech CFO David Jin's 2023 pay jumps 267% to $1.3M
April 5, 2024
Avalon GloboCare Corp. CEO David Jin's 2022 pay stays at $360K
September 8, 2023
Avalon GloboCare Corp. CEO David Jin's 2021 pay falls 64% to $360K
November 21, 2022
Avalon GloboCare Corp. CFO Luisa Ingargiola's 2020 pay slips 20% to $1.1M
December 13, 2021
Avalon GloboCare Corp. CFO Luisa Ingargiola's 2019 pay rises 3% to $1.3M
June 22, 2020
Avalon GloboCare Corp. CFO Luisa Ingargiola's 2018 pay jumps 34% to $1.3M
June 17, 2019